Process Intelligence Is Critical to the Pharmaceutical Enterprise - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Process Intelligence Is Critical to the Pharmaceutical Enterprise


Equipment and Processing Report

Untitled Document

For decades, companies have recognized the importance of understanding what is happening in their businesses at the enterprise level and using that information, known as business intelligence (BI), to make informed business decisions. This recognition led to the decision-support systems created in the 1970s and ultimately, in the 1990s, to the evolution of today’s more advanced BI systems. In the past decade, manufacturing intelligence (MI) systems, which access and aggregate manufacturing-related data from multiple sources, have gained significant momentum and increased their ability to focus on operational excellence.

Although MI gives companies valuable benefits, it does not provide the specific knowledge that all process manufacturers need. The key performance indicators (KPIs) that MI typically tracks and displays in dashboards are an important component of understanding what is taking place in the manufacturing organization. But once the enterprise level sees that yields are not in the expected range, for example, then the company must understand why, so that improvements can be made.

Fig 1 Process intelligence is a subset of manufacturing intelligence and business intelligence that provides information across process development, manufacturing, information technology, and contract manufacturing organizations groups. MI shows what is happening in the manufacturing process, and process intelligence explains why it is happening in actionable process terms, thus helping manufacturers realize important benefits such as better process control.
Figure 1: Process intelligence is a subset of manufacturing intelligence and business intelligence that provides information across process development, manufacturing, information technology, and contract manufacturing organizations groups. MI shows what is happening in the manufacturing process, and process intelligence explains why it is happening in actionable process terms, thus helping manufacturers realize important benefits such as better process control. Image is courtesy of the author.

The missing piece
What MI is not delivering today is process intelligence, a critical subset of MI (see Figure 1). Process intelligence helps users gain a specific understanding of their manufacturing processes and how to control their sources of variability. Once this information is widely available, it can be used to achieve manufacturing-process excellence throughout the entire product life cycle using appropriate technological tools.

MI shows what is happening in the manufacturing process, and process intelligence explains why it is happening. Process intelligence solutions enable an understanding of the physics, biology, and chemistry of materials, recipes, and manufacturing processes. This understanding helps manufacturers improve process predictability, reduce start-up risks, improve product quality, decrease cycle times, and increase yields and compliance—especially in complex production environments regulated by good manufacturing practice (GMP) and the US Food and Drug Administration.

Process intelligence solutions improve control
Building process intelligence into overall MI and BI portfolios using a self-service data-access platform linked directly to the operational data stores of existing manufacturing-data infrastructure systems allows users to understand the sources of process variability. This technique enables them to achieve better process control from the process-design stage (i.e., in process development) throughout the entire product life cycle. Appropriate technology solutions for process intelligence use a hierarchy to help access and contextualize data for users across multiple levels of the ISA-95 model, offering a full view of manufacturing and process-development data.

For example, one global pharmaceutical manufacturer needed to reduce the burden on end users who wanted to examine their process data easily with standardized tools without waiting for the data and then massaging it for hours in spreadsheets before it could be analyzed. The manufacturer needed a single common system to access, contextualize, analyze, and report data and help interdisciplinary global teams compare batches manufactured at different plants.

The manufacturer planned to replace its proprietary system and provide self-service data access, contextualization, and analysis in a single, validated environment. Previously, every scientist used Excel spreadsheets to prepare reports, and these files would end up scattered around on various desktops. The company needed a robust system that could withstand a good manufacturing practice (GMP) audit.

The company looked for the following characteristics in a new system:

  • Ease of implementation
  • Ease of use
  • Ease of maintenance
  • GMP readiness
  • Low total cost of ownership.

The IT department evaluated available commercial, off-the-shelf (COTS) systems according to these requirements and ultimately chose a COTS process intelligence platform for integrated self-service data access, contextualization, and analysis. The company realized that the data-aggregation, -contextualization, and -analytics offerings of commercially available data historians, enterprise resource planning systems, and statistics packages were not adequate to the task. The manufacturer needed the process-intelligence layer above these systems that made data available in a meaningful context to all levels of the enterprise.

Beneficial results
After the company deployed the process-intelligence platform, it reduced the amount of time required to gather data for annual product reviews (APRs) by more than 90%. The high burden on IT for the support and development of in-house systems was eliminated.

In the end, process manufacturers usually see the following significant business benefits when adding the previously missing process intelligence piece:

  • Increased effective plant capacity
  • Improved supply-chain predictability
  • Accelerated product release
  • Reduced APR-preparation time
  • Improved quality compliance
  • Capitalization on previous IT investments
  • Reduced total cost of ownership.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Equipment and Processing Report,
Click here